Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64f835edacb8ad08f214fd19fe8c27a5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 |
filingDate |
2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_575d5d5b0578df44d66b7024c14a4fe8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5491dca1447f0467d9b353a628aa0e78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32a09c0001fd2365533c58a2528d9ffb |
publicationDate |
2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101184725-B1 |
titleOfInvention |
Pharmaceutical composition for the treatment or prevention of liver fibrosis or cirrhosis comprising safoglylate |
abstract |
The present invention provides a pharmaceutical composition for the treatment or prevention of hepatic fibrosis or cirrhosis comprising safoglylate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160129121-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744113-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744114-B2 |
priorityDate |
2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |